Welcome to PharmCorp’s International Website! We are committed to your nations wellness, prosperity and productivity. Fighting the worlds crippling diseases, PharmCorp’s army of researchers, bred from the world’s top universities, work vigorously to find treatments and cures for debilitating illnesses that plague all nations. Distributing the pharmaceuticals through our brand name pharmacies, fast and efficient service is guaranteed for all your needs.
History
PharmCorp, started by Edward Weston in 1970 to combat the plethora of diseases that were prevalent in Brewdomian Society. Slowly, his tireless work as a single medicine shop owner, soon became a Brewdomian wide distributor of necessary vitals, saving the lives of millions through breakthrough research and efficient care. It is now necessary that we must focus on a global outreach to give those that are suffering from devastating illnesses another chance at something we all wish for. Life.
Mission Statement and Public Policy
As a key provider of essential needs to millions, PharmCorp finds it necessary to explain thoroughly its mission statement to the world. We strive to give patients the best affordability and accessibility to prescription and over the counter drugs that they may need. PharmCorp encourages investment to allow development of new affordable medication that can prevent and cure medical conditions. Due to the numerous obstacles that take a chemical to a drug, PharmCorp is researching innovative ways to make sure our medicines pass even the most rigorous of tests.
Once the potential drug passes through a series of tests and is readied for clinical trials, we first identify all safety precautions, thus giving the trial subject all necessary care in case of an emergency. Patient safety is one of the most important things a healthcare company strives for, and we are the one of the biggest sponsors of making sure the patient is helped, not harmed by a drug.
PharmCorp believes Intellectual Property rights are key in fostering innovation and competition among industry leaders, thus offering the patient a wide variety of options choose from.
Due to the numerous counterfeit drugs that are springing like wildfire across the world, it is necessary for adequate screening to find second-rate products which may harm a persons health. PharmCorp works with local law-enforcement to help eradicate these counter-feits and give local pharmacies and clinics easy access to assured safe ones from PharmCorp, where the demand of excellence never tires us out.
Investing
PharmCorp promises to maintain a reputation of excellence and integrity in its financial goals, always keeping stray from questionable practices that may harm the consumer. Our clean record in the past has helped us receive numerous accolades in financial excellence. An annual financial report is released and covers all facets of our financial dealings.
Corporate Transparency
In our society, we feel that it is necessary to be transparent in our corporate workings, and ensuring responsible business practices. We require every employee to learn a business ethics and responsibility manual in order to ensure maximum efficiency while doing it responsibly. Company policy allows issues to be discussed with confidentiality while promoting cooperation between our employees, who work tirelessly to implement our business practices.
Executive Leadership
CEO Michael Weston-Son of founder Edward Weston, Michael became an academic all star at Brentwood University in New Azura, earning his Masters in Business Administration from there. He went on to get a Doctorate at Tula Business and Medical Academy in Abruzi, a product of international excellence. Michael lives with his wife Kayla, and his three children in South Chromus, Brewdomia.
CFO Brook Winston-Born to a poverty stricken family in the slums of North San Gabriel, she became a athletic star and an academic genius, earning numerous accolades while going to Kentara University in Brewdomia to receive her Masters in Business Administration and her numerous science degrees. Brook lives in in South San Gabriel, while actively doing humanitarian work in North San Gabriel.
COO-Arnalia Vaazka- Born in The Methronnian Main Land Of Jenrak, she became a major player in the Amalgamates’ health care industry, and received numerous Azhukali accolades for her humanitarian and business practices. She is married to her husband Charles, and lives with her three children in Chromus.
PharmCorp in your nation.
For PharmCorp to begin and ensure quality patient care and added vitalization to your economy, simply state that PharmCorp is allowed to conduct responsible business practices on your soil.
Operating Currently In.
Amazonian Republic-967 Branches. Extremely Heavy R&D and Investment Operations. Patent Operations have begun. Projected Profit-$541,632,000,000
Abruzi-175 Branches R&D and Patent Operations have begun. Projected Revenue-$100,464,000,000
Allanea-15213 Branches. R&D, Investment and Patent Operations have begun. Projected Revenue-$851,928,000,000
The East Asian Union-179 Branches. R&D and Patent Operations have begun. Projected Revenue-$100,352,000,000
Ingramistan-107 Branches. R&D and Patent Operations have begun. Projected Revenue-$59,752,000,000
Shaff-159 Branches. R&D and Patent Operations have begun. Projected Revenue-$84,504,000,000
Unified Western States-400 Branches. R%D and Patent Operations have begun. Projected Revenue-$229,096,000,000
Satirius- 105 Branches. R&D, Investment and Patent Operations have begun. Projected Revenue-$56,280,000,000
Tutlingburg-246 Branches. R&D, Investment and Patent Operations have begun. Projected Revenue-$114,576,000,000
Naacal-195 Branches. R&D and Patent Operations have begun. Projected Revenue-$58,576,000,000
Jenrak Nakros Rephalim- 100 Branches. Heavy R&D and Heavy Investing.-Projected Revenue-$ 4,760,000,000
Ansari Empire-210 Branches. Heavy R&d and Heavy Investing. Patent Operations Underway. Projected Revenue-$117,824,000,000
Orelkjestad-155 Branches. R&D and Heavy Investing. Patent Operations Underway. Projected Revenue-$86,968,000,000
Blackhelm Confederacy-800 BranchesR&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$485,632,000,000
Cukarica-R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$191,856,000,000
The Master M- 210 Branches Heavy R&d And Heavy Investment. Patent Operations Underway. Projected Revenue-$122,080,000,000
Arabiak- 75 branches R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$43,960,000,000
Prevania-556 Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$315,000,000,000
Divair-228 Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$127,068,000,000
Knowlandia-20 Branches. Heavy R&D and Investment. Patent Operations Underway. Projected Revenue-$392,000,000
The State Of Monavia- 150 Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$25,869,003,338
Malikov-231 Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$129,864,000,00
Anemos Major-433 Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$242,928,000,000
Tiurabo-284 Branches. Heavy R&D and Heav Investment. Patent Operations Underway, Projected Revenue-$161,952,000,000
Libertarian Governance-104 Branches.Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$56,784,000,000
Mikedor-50 Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$23,352,000,000
Ustio North-531 Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$287,280,000,000
Kreigan-N/A Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$22,440,000,000
The Parthians-1382 Branches. Heavy R&D and Heavy Investment. Patent Operations Underway. Projected Revenue-$774,076,800,000
OOC: To Calculate My Revenue, I took Pfizer's first quarter earnings for the U.S, which has a population of 300 million. Depending on your nation size, I will see how many times 300 million goes into your nation's size, or if it doesnt I will divide it. I take that number and multiply it by 16.8 Billion, Pfzifer's First Quarter Revenue. The Revenue calculated is for the entire Fiscal Year.
